Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works citing this work

5 works

Work: Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies

  1. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

    Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

    ArticleCAR-T cell therapy researchJournal of Hematology & Oncology20250 citations
    ABI

  2. Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety

    Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

    ArticleCAR-T cell therapy researchDiscover Oncology20260 citations
    ABI

  3. Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy

    Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

    ArticleCancer Immunotherapy and BiomarkersAnnals of Hematology20260 citations
    ABI

  4. Advances in monitoring and therapy from minimal residual disease to CAR-T cells in multiple myeloma and precursor disorders

    Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Ghaleb Oriquat, Sokhib Saidov +5

    ArticleCAR-T cell therapy researchClinica Chimica Acta20260 citations
    ABI

  5. CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy

    E. A Nemilostiva, O. A Paevskaya, Shuxrat Boymuradov +2

    ArticlePluripotent Stem Cells ResearchClinical & Translational Oncology20260 citations
    ABI